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ABSTRACT Trehalose is an essential disaccharide for mycobacteria and a key con-
stituent of several cell wall glycolipids with fundamental roles in pathogenesis. My-
cobacteria possess two pathways for trehalose biosynthesis. However, only the
OtsAB pathway was found to be essential in Mycobacterium tuberculosis, with marked
growth and virulence defects of OtsA mutants and strict essentiality of OtsB2. Here,
we report the ﬁrst mycobacterial OtsA structures from Mycobacterium thermoresist-
ibile in both apo and ligand-bound forms. Structural information reveals three key
residues in the mechanism of substrate preference that were further conﬁrmed by
site-directed mutagenesis. Additionally, we identify 2-oxoglutarate and 2-phospho-
glycerate as allosteric regulators of OtsA. The structural analysis in this work strongly
contributed to deﬁne the mechanisms for feedback inhibition, show different confor-
mational states of the enzyme, and map a new allosteric site.
IMPORTANCE Mycobacterial infections are a signiﬁcant source of mortality world-
wide, causing millions of deaths annually. Trehalose is a multipurpose disaccharide
that plays a fundamental structural role in these organisms as a component of my-
colic acids, a molecular hallmark of the cell envelope of mycobacteria. Here, we de-
scribe the ﬁrst mycobacterial OtsA structures. We show mechanisms of substrate
preference and show that OtsA is regulated allosterically by 2-oxoglutarate and
2-phosphoglycerate at an interfacial site. These results identify a new allosteric site
and provide insight on the regulation of trehalose synthesis through the OtsAB
pathway in mycobacteria.
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Trehalose is a nonreducing disaccharide, formed by -(1-1)-linked glucoses, with awide distribution in nature and present in all three domains of life (1). This
remarkably widespread sugar performs multiple roles in a wide variety of organisms,
and it can also fulﬁll different roles within the same organism. Trehalose has been
considered a compatible solute, conferring protection on proteins, DNA, membranes,
and whole cells from thermal shock, osmotic shock, freezing, ionizing radiation, oxida-
tive stress, and desiccation (1–9). This disaccharide, which can further function as a
carbon and energy reserve molecule (1, 10–12), was also recently related to the
pathogenicity of Pseudomonas aeruginosa in plants (13). It additionally plays funda-
mental signaling roles in plants, in the phosphorylated form (trehalose-6-phosphate),
where it regulates sucrose metabolism and ﬂowering (1, 14–16), and in yeast, where it
regulates gluconeogenesis and glycolysis (17, 18). Trehalose was further shown to be an
autophagy inducer, both in plants and in mammals, with potential biotechnological
and clinical implications (19, 20).
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In mycobacteria, trehalose is also an essential component of mycolic acids and other
cell wall glycolipids, which are major protagonists in pathogenesis of Mycobacterium
tuberculosis (1), the causative agent of the widespread infectious disease tuberculosis.
In these organisms, trehalose was further identiﬁed as a key signaling molecule of cell
envelope stress, playing a role as an activator of the iniBAC operon, which is induced
when mycobacteria are exposed to the ﬁrst-line drug isoniazid (21).
All mycobacterial species, with a few exceptions, possess two pathways to synthe-
size trehalose, the OtsAB and the TreYZ pathways (1). The OtsAB pathway is the most
widely distributed trehalose biosynthesis pathway, present in bacteria, archaea, and
eukaryotes (22, 23). In this pathway, which is conserved and essential in mycobacteria,
trehalose is synthesized in a two-step process involving OtsA and OtsB2 enzymes. M.
tuberculosis mutants showed that the OtsAB pathway was not only the dominant route
for trehalose biosynthesis in this pathogen but also required for growth both in vitro
and in a mouse infection model, with marked growth and virulence defects of OtsA
mutants (24) and strict essentiality of OtsB2 due to the toxic effect of trehalose-6-
phosphate (T6P) accumulation (24, 25).
OtsA, a glycosyltransferase that belongs to the GT20 family of the CAZY classiﬁcation
(www.cazy.org), uses the  anomer of glucose-6-phosphate (G6P) as acceptor and
nucleoside diphosphate glucose (NDP-glucose) as the donor to synthesize T6P, with net
retention of the anomeric conﬁguration of the donor substrate (26, 27). Binding of the
substrates occurs sequentially in a “bi-bi mechanism” with NDP-glucose binding ﬁrst
and G6P second (26, 28). Interestingly, OtsAs from different organisms show different
donor preferences as shown by kinetic studies and X-ray crystal structures, but the
reasons behind these preferences are poorly understood (27, 29–33). Recently, different
roles were identiﬁed for OtsA beyond its enzymatic activity. OtsA was reported to act
as an osmotic stress sensor and morphogenetic protein that can regulate the switch to
mycelioid growth in Arthrobacter sp. strain A3, a pleomorphic soil-dwelling actinobac-
terium (34).
In this work, we puriﬁed, crystallized, and solved the structure of Mycobacterium
thermoresistibile OtsA (MtrOtsA). To gain further insight into the substrate preference of
mycobacterial OtsAs, we have obtained structures with substrates that deﬁne the
mechanisms of ADP-glucose preference. Structure-guided point mutations of key
residues in the active site were performed, and characterization of the mutants showed
that three mutations are enough to change the donor substrate preference to UDP-
glucose. Further structures with OtsA product and pathway product were obtained,
showing how this enzyme is feedback inhibited by trehalose. Importantly, with these
structures, we have also identiﬁed a new allosteric site and allosteric regulators of this
enzyme that link glycolytic and tricarboxylic acid (TCA) cycle metabolites to the
regulation of trehalose synthesis.
RESULTS
Overall structure. The structure of MtrOtsA in its apo form was solved by molecular
replacement, using the Escherichia coli OtsA structure (PDB code 1UQU) as the search
model (see Fig. S1 in the supplemental material). Data collection and reﬁnement
statistics are summarized in Table S1. MtrOtsA is composed of two Rossmann-fold
domains with a deep catalytic site at their interface, in an arrangement typical of GT-B
glycosyltransferases as described previously for other organisms (27, 29, 30). The apo
protein crystallized in the I4122 space group, with one protomer per asymmetric unit,
and diffracted to 1.8-Å resolution. The N-terminal domain is formed by a core of 7
parallel -strands ﬂanked on both sides by an antiparallel -strand and surrounded by
8 -helices, one of which is composed of the ﬁnal C-terminal residues (Fig. 1A). The
C-terminal domain contains 6 parallel -strands associated with 9 -helices with the last
one undergoing a kink and extending to the N-terminal domain, characteristic of the
GT-B fold glycosyltransferases (Fig. 1A). Analysis of the B-factor distribution shows that
the N-terminal domain has the highest values for atomic temperature factors, suggest-
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ing that this domain is more dynamic, which is consistent with the large movements of
-1 during catalytic activity.
MtrOtsA forms a tetramer in solution, as previously observed for M. tuberculosis
OtsA. This tetrameric form is also observed in all the crystal structures reported here
(Fig. 1B). The amino acids involved in the tetramer interfaces are not conserved beyond
mycobacteria and related species (Fig. S2), suggesting that OtsA might have a different
molecular assembly in different species. Indeed, in E. coli both tetrameric and dimeric
forms were reported (27) while in Streptomyces venezuelae and Aspergillus fumigatus
only the dimeric form was observed (29, 30). However, in mycobacteria and closely
related organisms the tetramer interfaces are highly conserved, suggesting a tetrameric
assembly of OtsA in all of these organisms (Fig. S2).
Catalytic site. OtsA is a glycosyltransferase that uses the  anomer of G6P as
acceptor and NDP-glucose as the donor to synthesize T6P. The MtrOtsA catalytic site is
located between the two Rossmann fold domains in a large and deep cavity. Structures
with donor substrates were determined by soaking the apo form crystals with ADP-
glucose and GDP-glucose (Fig. 2). The donor substrates interact primarily with the
C-terminal domain through the side chains of the highly conserved Arg286, Lys291,
Asp385, and Glu393 and with the side chain of Arg365 (Fig. 2), which is conserved in
all mycobacteria and closely related species but less conserved outside this group
(Fig. S2). Backbone interactions with the absolutely conserved residue Gly386, Met387,
Asn388, and Leu389 amine groups are also observed. Similar interactions were ob-
served before for E. coli OtsA (27, 32). While the adenine moiety interacts with the
Val363 amino group, the Leu319 carbonyl, and a coordinated water (Fig. 2A), the
guanine moiety forms interactions with Val363 only (Fig. 2B). N-terminal domain
interactions with the donor substrate are observed only for His168 when the active site
is in an open conformation (Fig. 2). To obtain a structure with the acceptor substrate,
we cocrystallized OtsA in the presence of 5 mM ADP and G6P. As G6P binds to the
protein in the presence of a donor substrate or its nucleotide, the active site adopts a
closed conformation (Fig. 3A). The OtsA:ADP:G6P ternary complex crystallized in the
P6222 space group, with one protomer per asymmetric unit, and the crystals diffracted
up to 1.7-Å resolution. In this closed conformation, new interactions with the donor
substrate are formed with the Gly39 peptide-NH function (Fig. 3). Due to the absolute
conserved nature of Gly39 among all functional OtsAs and related enzymes (27) and the
contact that it forms with the glucose-bound phosphate, this residue is highly likely to
be mechanistically involved in the catalytic activity (27).
The acceptor interactions recapitulate what was observed before for E. coli (27) with
the substrate interacting with the highly conserved residues Arg18, Tyr90, Asp144, and
Gln146 of the N-terminal domain and with only a single residue of the C-terminal
domain, Arg324 (Fig. 3B). The residues involved in acceptor substrate interaction are
highly conserved across both bacteria and yeast (Fig. S2). As described for E. coli OtsA
FIG 1 (A) Representation of the overall structure of M. thermoresistibile OtsA. The N-terminal domain
consists of residues 1 to 247 and 462 to 486, and the C-terminal domain consists of residues 248 to 461.
(B) View of M. thermoresistibile OtsA tetramer.
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(27), the OtsA:ADP:G6P ternary structure shows the catalytic site in a closed conforma-
tion that substantially differs from the apo form, with -helix 1 and the Arg35-Gly39
loop region moving up to 12 Å (Fig. 3A).
Properties of M. thermoresistibile OtsA. MtrOtsA uses ADP-glucose, UDP-glucose,
and GDP-glucose as glucose donors with a preference for ADP-glucose (Table 1) and
G6P as the only acceptor, in accordance with what was reported before for M.
tuberculosis OtsA (33, 35). The kinetic parameters for MtrOtsA were obtained and are
reported in Table 1 and Fig. S3 with Kmapp values for the preferred donor substrate
(ADP-glucose) of 0.25 0.02 mM and for the acceptor (G6P) of 3.3 0.1 mM. The Kmapp
for GDP-glucose of 0.29 0.02 mM was in the same range as the one obtained for
ADP-glucose; however, the turnover was 5-fold lower (Table 1). For UDP-glucose, the
enzyme showed an 7-fold-higher Kmapp of 1.7 0.1 mM than the one obtained for
ADP-glucose (Table 1).
The preference of ADP-glucose over the other glucose donors was further conﬁrmed
by isothermal titration calorimetry (ITC). The binding afﬁnity of substrate donors could
be determined only for ADP-glucose under the tested conditions with an observable Kd
(dissociation constant) of 27.17 2.66 M (Fig. S4). Other glucose donors analyzed
(GDP-glucose and UDP-glucose) had no observable heat of binding, and the same was
observed for G6P. The lack of heat of binding for GDP- and UDP-glucose is most likely
due to their reduced afﬁnity. In the case of G6P, it reﬂects a necessity of previous
binding of the donor substrate.
Donor substrate preference is largely mediated by three residues. OtsAs from
different organisms have been shown to have different donor substrate preferences,
while being capable of using several nucleotide donors (30, 33, 36, 37), which is
reﬂected in lower conservation of the donor substrate-interacting residues (Fig. S2).
Preference for ADP-glucose as the donor substrate in MtrOtsA is conferred by interac-
tions with the deeply buried adenine moiety (Fig. 4A). The carbonyl groups of Leu319
FIG 2 Detailed view of the active site of M. thermoresistibile OtsA with ADP-glucose (A) and with GDP-glucose (B) bound with Fo-Fc
“omit maps” shown contoured at 1.5 . Black dashed lines represent hydrogen bonds.
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and Arg361 interact with the primary amine, and the amide group of Val363 interacts
with N-1 of the adenine moiety (Fig. 4A). A highly coordinated water interacts with the
primary amine of the adenine moiety and the carbonyl groups of Leu359 and Arg361.
The guanine moiety of GDP-glucose does not occupy the same deeply buried pocket
as the adenine because its primary amine group would sterically clash with the Val363
carbonyl group (Fig. 4B). It thus binds to OtsA more weakly than ADP-glucose, explain-
ing the substrate preference and consequently the lack of observable heat of binding
under the tested ITC conditions. A binary complex structure with OtsA and UDP-
glucose was also obtained, but the electron density was observed for only glucose and
the two phosphates (not shown), indicating a reduced preference for this substrate as
conﬁrmed by enzymatic and biophysical data. Comparing the OtsA structures of M.
thermoresistibile and E. coli, we hypothesized that the ADP preference was mediated by
the substitution of an isoleucine (Ile295 in E. coli) for a leucine (Leu319 in M. thermore-
sistibile). The presence of the leucine in M. thermoresistibile allows the primary amine of
the adenine moiety to occupy a buried position, interacting with the carbonyl group of
Leu319 (Fig. 4C) which no other nucleotide activated donor can occupy. However,
given the differences between the two enzymes, it is likely that other residues could
also play a role. To improve the selection of residues to mutate, we employed a
computational approach using mCSM-lig (38), a software program developed by our
group that predicts the effects of mutations on binding afﬁnity. The software predicted
that several residues within 4.5 Å of the adenine moiety have a destabilizing effect on
the interactions between M. thermoresistibile OtsA and ADP-glucose if mutated to the
E. coli OtsA equivalent (Table S2). Combining this information with structural analysis,
three mutations predicted to be destabilizing were selected. These mutations are
Val363Phe, Leu319Ile, and Glu367Leu, the last being a long-distance mutation that we
hypothesized would have a strong effect on ligand binding.
To conﬁrm our hypothesis, we generated several MtrOtsA mutants (Leu319Ile,
Val363Phe, Leu319Ile-Glu367Leu, and a triple mutant) and obtained kinetic data for
FIG 3 (A) View of OtsA in an open (salmon and red) and a closed (violet and blue) conformation and superposition
of the two conformations. (B) Representation of the active site of M. thermoresistibile OtsA with ADP (white) and
G6P (yellow) bound with Fo-Fc “omit map” shown contoured at 1.5 . Black dashed lines represent hydrogen
bonds.
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these mutants (Table 1). As predicted, the mutant Leu319Ile showed an 3-fold
increase in the Kmapp for ADP-glucose whereas Kmapp values were similar for GDP-
glucose and UDP-glucose compared to the wild type. Even though GDP-glucose now
showed the best Kmapp among the three different donors, the catalytic efﬁciency and
turnover rate were still higher for ADP-glucose (Table 1). A complete reversal of the
donor substrate preference for UDP-glucose was obtained only with a combination of
the three mutations (Table 1). The triple mutant showed an 5-fold increase in
ADP-glucose Kmapp and a reduction for the UDP-glucose Kmapp by more than 3-fold
(Table 1). The catalytic efﬁciency was also completely reversed for ADP- and UDP-
glucose between the wild type and the triple mutant (Table 1). Although Leu319Ile
showed the largest contribution to ADP-glucose Kmapp increase, Val363Phe and
Glu367Leu were also determinant for the reversal to UDP-glucose preference (Table 1).
This can be explained by the fact that the phenylalanine substitution at position 363
forces the loop between -14 and -14 to move toward the nucleotide binding site
(Fig. 4C), thus establishing stronger interactions with a pyrimidine nucleotide and
clashing with purine nucleotides. This effect is also observed for both ADP- and
GDP-glucose, with an 2.5-fold increase in Kmapp over the wild type. The leucine
substitution at position 367 further helps in this move since the hydrogen bonds
between the side chains of Arg266 and Glu367 are no longer present and -14 is
repelled from Arg266 due to the Leu side chain (Fig. 4C).
Feedback inhibition.We soaked both trehalose and T6P into apo OtsA crystals and
solved structures with both ligands (Fig. 4D and E). In both structures, the OtsA active
TABLE 1 Kinetic parameters of M. thermoresistibile OtsA
Genotype and substrate Kmapp (mM) kcatapp (s1) kcat/Km (s1 · mM1)
Wild type
ADP-glucose 0.25  0.02 26  1 104  13
GDP-glucose 0.29  0.02 5.1  0.2 18  2
UDP-glucose 1.7  0.1 36  1 21  2
Glucose-6-phosphate 3.3  0.1 26  1 7.9  0.5
L319I
ADP-glucose 0.71  0.18 8.4  0.7 12  2
GDP-glucose 0.35  0.04 3.1  0.1 8.9  1.4
UDP-glucose 1.4  0.1 8.9  0.4 6.4  0.7
Glucose-6-phosphate 3.3  0.2 6.4  0.2 1.9  0.2
V363F
ADP-glucose 0.60  0.03 11  1 18  2
GDP-glucose 0.74  0.08 14  1 19  3
UDP-glucose 0.68  0.06 13  1 19  3
Glucose-6-phosphate 3.1  0.2 19  1 6.1  0.7
L319I, E367L
ADP-glucose 0.63  0.04 14  1 22  3
GDP-glucose 0.70  0.05 9.2  0.4 13  2
UDP-glucose 0.63  0.03 15  1 24  3
Glucose-6-phosphate 3.7  0.2 21  1 5.7  0.5
L319I, V363F, E367L
ADP-glucose 1.3  0.1 19  1 15  2
GDP-glucose 0.90  0.06 16  1 18  2
UDP-glucose 0.52  0.05 22  1 42  6
Glucose-6-phosphate 3.2  0.2 17  1 5.3  0.6
R213E
ADP-glucose 0.31  0.01 56  2 180  13
Glucose-6-phosphate 3.3  0.3 33  2 10  1
R384E
ADP-glucose 1.9  0.2 3.2  0.1 1.7  0.2
Glucose-6-phosphate 2.9  0.2 2.1  0.2 0.77  0.05
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site assumes an open conformation and two compounds superpose almost perfectly at
the active site, recapitulating all of the interactions for the donor glucose and also
interacting with His199 and Arg286, the latter a residue that interacts with the phos-
phates of the donor substrate (Fig. 4D and E). The structure with T6P further shows the
phosphate group of the product occupying a similar position as the phosphate group
of G6P, interacting with the side chains of Tyr90, Gln146, Arg324, and Tyr145, a residue
that does not interact with G6P (Fig. 4E). Interestingly, the buffer present under the
crystallization condition, N-cyclohexyl-2-aminoethanesulfonic acid (CHES), is observed
in both trehalose- and trehalose-6-phosphate-bound structures, occupying the site of
the nucleotide donor with the sulfate group binding in a phosphate site and interacting
with hydroxyl groups from both glucose units of trehalose (Fig. 4D and E).
After obtaining these structures, we expected to observe some degree of feedback
inhibition of OtsA by trehalose given that, under physiological conditions, free treha-
lose is highly abundant inside mycobacterial cells, reaching up to 15% of the total
organic material in actively growing Mycobacterium smegmatis cells (39), while T6P
could not be detected inM. tuberculosis cell extracts (25). Trehalose was found to inhibit
the enzyme with a 50% inhibitory concentration (IC50) of 24 mM (Fig. S5). These
results suggest that under physiological conditions, OtsA can be regulated by trehalose,
the ﬁnal product of the pathway which is highly abundant inside mycobacterial cells
(39).
Identiﬁcation of an allosteric site in M. thermoresistibile OtsA. Trehalose is a
multipurpose molecule that is abundant in mycobacteria. It not only can function as an
energy reserve and as structural component of cell wall glycolipids but can also lead to
the synthesis of glycogen through the TreS-Mak-GlgE pathway and be directly synthe-
sized from glycogen from the TreX-TreY-TreZ pathway. It is therefore likely that
trehalose synthesis through the OtsA-B pathway is under strong regulation.
FIG 4 View of the binding site of the adenine moiety of ADP-glucose. (A) A water that mediates the adenine moiety interaction with OtsA
is represented as a red sphere. (B) Superposition of ADP-glucose and GDP-glucose structures. (C) Superposition of MtrOtsA structure with
ADP-glucose bound and E. coli OtsA structure with UDP-glucose bound (PDB code 1UQU). -helix 14 (-14) and -strand 14 (-14) are
shown. (D and E) Detailed view of the active site of M. thermoresistibile OtsA with trehalose (D) and with T6P bound (E) with CHES visible
in both structures. Fo-Fc “omit maps” are shown contoured at 1.5  for trehalose, T6P, and CHES. Black dashed lines represent hydrogen
bonds.
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Under all the crystallization conditions that contained CHES, we could observe this
compound in the crystal structures occupying a pocket formed by the contact interface
of two OtsA protomers in the tetrameric assembly (Fig. 5). The CHES sulfate group
directly interacts with the side chains of Arg384 of protomer A and Arg213 of protomer
B, forming hydrogen bonds with both but also hydrogen- interactions with Phe410 of
protomer A (Fig. 5). The residues composing this site are completely conserved in
mycobacterial and closely related species that are likely to harbor OtsA tetramers but
not in other species known to have other oligomeric forms (Fig. S2).
Arg384 sits in a loop that forms extensive contacts with the donor substrate through
Asp385, Gly386, Met387, and Leu389 (Fig. 2). Ligands interacting with the side chain of
Arg384 could therefore have an impact on the activity of the enzyme, making this site
a prime candidate for allosteric regulation.
While CHES had no discernible impact on OtsA activity at the tested concentrations,
it was reported before that F6P acted as an allosteric regulator of M. tuberculosis OtsA
(35), and the same was reported for the yeast OtsA-B complex (40). We have tested
MtrOtsA under the same conditions as those reported by Asencion Diez and colleagues
(35) and could not detect any effect of F6P for MtrOtsA. Although we did not observe
any effect of F6P on enzyme activity for MtrOtsAs, we nevertheless attempted to soak
this compound in both apo form and OtsA:ADP:G6P ternary complex crystals and also
cocrystallize it in the presence and absence of ADP and G6P, all under CHES-free
conditions. None of these conditions provided a structure in which F6P occupied an
allosteric site. We could, however, observe F6P when cocrystallized together with ADP,
bound to the acceptor substrate site, with OtsA presenting the active site in a closed
conformation (Fig. S6).
OtsA was found to interact with a multitude of proteins in a large-scale proteomics
study (41), including enolase, which catalyzes the penultimate step of glycolysis. In our
search for an allosteric regulator, we therefore decided to test several glycolytic
FIG 5 (A) View of the allosteric site of M. thermoresistibile OtsA with CHES bound with protein surface electrostatic potential shown. (B)
Detailed view of the CHES binding site and its interactions with OtsA. The interactions were calculated with Arpeggio (61) using the apo
structure (5JIJ). Black dots represent hydrogen bonds, and yellow disks represent a carbon- interaction. The two protomers are colored
differently. (C) Activity proﬁles of M. thermoresistibile wild-type OtsA and the allosteric site mutants Arg213Glu and Arg384Glu in the
presence of the allosteric effectors 2OG and 2PG.
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metabolites, glucose-1-phosphate (G1P), fructose-1,6-biphosphate (F16BP), 3-phospho-
glycerate (3PG), the enolase substrate 2-phosphoglyceric acid (2PG), and the product
phosphoenolpyruvate (PEP), but also the master metabolic regulators cAMP and
2-oxoglutarate (2OG) (42) and assess their impact in OtsA activity.
From the several compounds tested, only 2OG and 2PG showed clear inhibition of
OtsA activity with IC50s of 1.8 mM and 2.3 mM, respectively (Table 2 and Fig. 5C). To
assess whether they could be acting allosterically on MtrOtsA and binding to the site
identiﬁed by CHES, we performed two mutations on the arginines that interacted with
CHES (Arg213Glu and Arg384Glu) and tested the two mutants’ activity in the presence
of 2OG and 2PG. The results show that the Arg213Glu mutation abolished the strong
response of the protein to 2OG while there was an 5-fold increase in 2PG IC50 to
12 mM. For the Arg384Glu mutant, 2OG unexpectedly becomes a strong activator with
a 50% effective concentration (EC50) of 0.7 mM while 2PG has no effect (Table 2).
DISCUSSION
Trehalose, an essential disaccharide in mycobacteria, is one of the critical compo-
nents of the cell wall. The OtsA-B pathway is an essential source of trehalose for these
organisms, with knockouts of this pathway being growth defective or nonviable (24,
25). Here, we reveal the ﬁrst mycobacterial OtsA structure. The overall structure of M.
thermoresistibile OtsA is similar to the reported structures of E. coli, S. venezuelae, and
Paraburkholderia xenovorans OtsAs despite relatively low sequence identity (30 to 35%).
Remarkably, OtsAs also have a fold highly similar to the pseudoglycosyltransferases
VldE and ValL involved in synthesis of validamycin A, a potent antifungal agent (43, 44).
Nevertheless, there are substantial differences in the oligomeric organization of
bacterial OtsAs, with tetrameric, dimeric, and protomeric forms reported. While myco-
bacteria and related species present conservation of interfaces, showing that the
observed tetrameric form for MtrOtsA is present in all these organisms, beyond this
group such conservation is absent, which is consistent with other oligomeric states (see
Fig. S2 in the supplemental material).
The structures obtained in this work allow us to explain how mycobacterial OtsA
prefers ADP-glucose as a substrate. A cavity found to accommodate the binding of the
adenine moiety is surrounded with Leu319 and Arg361, which are critical for substrate
recognition. It is further mediated by the Val363 carbonyl group, which does not allow
GDP-glucose to occupy the same position, and by Glu367. Mutating these three
residues to the E. coli OtsA equivalents completely changed the preference to UDP-
glucose, the preferred E. coli OtsA donor substrate. Both Leu319 and Glu367 are highly
conserved in all mycobacterial and closely related species analyzed but not beyond this
group, while Val363 can be replaced by other small hydrophobic amino acids, such as
alanine and isoleucine, in other mycobacterial species and closely related species
(Fig. S2). However, outside this group Val363 is replaced by bulkier residues, such as
tyrosine and phenylalanine (Fig. S2). These differences are suggestive of alternative
donor substrate preferences for organisms outside the suborder Corynebacterineae.
Trehalose is not only abundant inside the mycobacterial cell but also involved in a
cycle that links it to the synthesis and degradation of glycogen (45). We have shown
that OtsA is feedback inhibited by trehalose but not by T6P, even though the structures
TABLE 2 Effect of allosteric regulators in M. thermoresistibile OtsA activity
Genotype
Value for allosteric regulator (95% conﬁdence interval)
2OG 2PG
IC50 (mM) nHb IC50 (mM) nH
Wild type 1.8 (1.6–2.1) 1.4 (1.1–1.7) 2.3 (2.0–2.7) 2.0 (1.4–2.7)
R213E 73 (18–302) 0.26 (0.16–0.35) 12 (6.3–24) 0.51 (0.40–0.63)
R384E 0.8 (0.6–0.9)a 2.5 (1.4–3.5) 100
aValue for 2OG for R384E is EC50 (mM), not IC50.
bnH, Hill coefﬁcient.
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obtained show that both compounds form extensive interactions with OtsA. However,
given that these two structures were obtained by soaking apo-form crystals with high
concentrations of trehalose and T6P and that CHES is also observed at the active site
interacting with both compounds, it is possible that these two structures do not
entirely reﬂect their natural interactions with the enzyme. The toxic accumulation of
T6P in OtsB2-knockout mutants (25) can be explained by these results, since OtsA
shows very low sensitivity to T6P. Furthermore, trehalose levels are reduced in the
mutant (25), further contributing to an increase in OtsA activity, leading to higher T6P
production.
Regulation of OtsA by phosphorylation and methylation has been observed for
yeast trehalose-6-phosphate synthase complex (46, 47), and phosphorylation of E. coli
OtsA has also been reported (48) in two residues close to the active site. Even though
only one of the residues is conserved in mycobacteria (Ser323 for MtrOtsA), phosphor-
ylation of this residue would most likely lead to inactivation of the enzyme due to the
location close to the acceptor binding site (Fig. S7). Interestingly, this residue is highly
conserved in all sequences analyzed, with a single exception where it is replaced by a
threonine (Fig. S2), suggesting that phosphorylation of this residue might be a common
regulatory mechanism of OtsA activity.
Allosteric regulation was reported for both M. tuberculosis OtsA and yeast trehalose
phosphate synthase complex, mediated by F6P (35, 40). The structure obtained with
F6P shows this compound occupying the donor site, in the presence of ADP, with the
enzyme adopting a closed conformation. Nevertheless, OtsA could use only G6P as an
acceptor, and F6P showed no effect on the enzyme activity, indicating that the
presence of F6P in the acceptor site was forced by the high concentration used for
cocrystallization (5 mM). The observed differences in regulation by F6P between my-
cobacterial enzymes are difﬁcult to reconcile since the allosteric site is highly conserved
in mycobacterial OtsAs and closely related species (Fig. S2).
MtrOtsA is allosterically regulated by 2PG, the substrate of enolase, a glycolytic
enzyme, and 2OG, a master metabolic regulator that sits at the interface of carbon and
nitrogen metabolism. The observed effect is within relevant physiological concentra-
tions for both compounds (49, 50).
The effect of 2PG on OtsA and the reported interaction with enolase suggest an
interplay between these two enzymes that would be interesting to explore further on
the enolase side. Enolase is a multifunctional protein involved in a variety of cellular
processes, beyond its enzymatic activity, which include response to oxidative and
thermal stress (51). Given that trehalose is a known chemical chaperone and compat-
ible solute (1), the association between enolase and OtsA, through the effect of 2PG on
OtsA activity and the reported interaction between the two enzymes, points to further
regulation of stress response.
2OG is a molecule that sits at the interface of carbon and nitrogen metabolism and
that has been shown to regulate many different pathways (42). The role of trehalose as
an energy reserve molecule (1) and its relationship with synthesis and degradation of
glycogen (52) point to a mechanism in which 2OG inﬂuences the synthesis of these two
compounds through regulation of OtsA activity, one that deserves to be further
explored.
We have shown that OtsA can be allosterically inhibited; however, a single mutation
at the allosteric site changed the behavior of 2OG, but not 2PG, from an inhibitor to an
activator. This hints at the possible existence of allosteric activators of OtsA yet to be
discovered.
The conservation of allosteric site residues and oligomeric assembly in the suborder
Corynebacterineae but not outside suggests that allosteric regulation of OtsA through
this site might be limited to this group of organisms. The results of this work are a
signiﬁcant step forward in understanding the regulation of trehalose synthesis in
mycobacteria and the structural reasons behind substrate preference and provide new
important insight into this enzyme.
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MATERIALS AND METHODS
Bacterial strains and cloning. The M. thermoresistibile (DSM 44167) otsA gene was ampliﬁed from
chromosomal DNA obtained from the Deutsch Sammlung von Mikroorganismen und Zellkulturen GmbH
(DSMZ; Braunschweig, Germany). Primers were designed based on the sequence available in the NCBI
database, and the gene was cloned between the BamHI and HindIII sites in pET28a vector (Novagen),
modiﬁed with an N-terminal 6His-SUMO tag. The resulting plasmid was conﬁrmed by DNA sequencing
and transformed into E. coli strain BL21(DE3) (Invitrogen). Six MtrOtsA mutants (Arg213Glu, Leu319Ile,
Val363Phe, Arg384Glu, Leu319Ile-Glu367Leu, and Leu319Ile-Val363Phe-Glu367Leu) were also con-
structed by site-speciﬁc mutagenesis, sequenced, and transformed into E. coli strain BL21(DE3). Primers
used in this work are listed in Table S3 in the supplemental material.
Recombinant expression and protein puriﬁcation. Transformed E. coli BL21(DE3) cells were grown
to mid-exponential growth phase (optical density at 610 nm [OD610]  0.6) in LB medium (Invitrogen)
containing 30 mg liter1 kanamycin at 37°C. Isopropyl--D-1-thiogalactopyranoside (IPTG) was then
added at a ﬁnal concentration of 0.5 mM to induce gene expression, and the temperature was lowered
to 18°C. Cells were harvested 18 to 20 h later by centrifugation and resuspended in 20 mM Tris (pH 7.5),
500 mM NaCl, and 20 mM imidazole with protease inhibitor tablets (Roche), DNase I, and 5 mM MgCl2.
Cells were lysed by sonication, and cell lysate was centrifuged at 27,000  g for 30 min to remove cell
debris.
Recombinant MtrOtsA was puriﬁed with a HiTrap IMAC Sepharose FF column (GE Healthcare),
equilibrated with 20 mM Tris (pH 7.5), 500 mM NaCl, and 20 mM imidazole. Elution was performed in the
same buffer but with 500 mM imidazole. Imidazole was removed with a desalting column, and SUMO tag
was cleaved overnight at 4°C by adding Ulp1 protease at a 1:100 ratio in 20 mM Tris (pH 7.5), 500 mM
NaCl. SUMO tag, Ulp1 protease, and uncleaved SUMO-OtsA were removed with a HiTrap IMAC Sepharose
FF column (GE Healthcare), equilibrated with 20 mM Tris (pH 7.5), 500 mM NaCl, and 20 mM imidazole.
Flowthrough containing OtsA was collected, concentrated, and loaded to a Superdex 200 column
equilibrated with 20 mM Tris (pH 7.5), 500 mM NaCl. Fraction purity was determined by SDS-PAGE, and
the purest fractions were pooled, concentrated to 10 mg · ml1 in 20 mM Tris (pH 7.5)-350 mM NaCl,
ﬂash frozen in liquid nitrogen, and stored at 80°C. The same puriﬁcation protocol was used for all
MtrOtsA mutants.
Crystallization and data collection. MtrOtsA crystallization screens and optimization were per-
formed at 18°C using the sitting-drop vapor diffusion method. Three hundred nanoliters of pure OtsA at
10 mg · ml1 was mixed in a 1:1 ratio with well solution using a Phoenix robot (Art Robbins). Initial
conditions were obtained in the Classics Suite crystallization screen (Qiagen), solution 36. Crystals
obtained under this condition diffracted only up to 3 Å. Therefore, further optimization was performed
using the additive screen HT (Hampton Research), and ethylene glycol was found to be the best additive.
The ﬁnal optimized condition consisted of 0.7 M sodium potassium tartrate, 0.1 M CHES (pH 10), and 10%
(vol/vol) ethylene glycol. Crystals appeared after 4 days under this condition. To obtain ligand-bound
structures, soaking was performed under the optimized condition using the hanging-drop vapor
diffusion method as follows: 1 l of protein storage buffer containing 5 mM ligand was mixed with 1 l
of reservoir solution, and drops were left to equilibrate against 500 l of reservoir solution for 3 days.
Crystals were then transferred to the preequilibrated drops and incubated for 24 h. A cryogenic solution
was prepared by adding ethylene glycol up to 25% (vol/vol) to mother liquor. Crystals were brieﬂy
transferred to this solution, ﬂash frozen in liquid nitrogen, and stored for data collection. To obtain an
ADP-G6P-OtsA ternary complex, cocrystallization with 5 mM ADP and G6P was performed instead, as all
attempts to soak G6P alone or G6P in the presence of ADP have failed. Crystals were obtained in the
Wizard Classic I&II screen (Rigaku), solution E10, and were ﬂash frozen in liquid nitrogen after a brief soak
in a solution containing mother liquor and 25% ethylene glycol. The same condition was used to obtain
ADP:F6P:OtsA complex.
All data sets were collected at stations I04, I04-1, and I24 at Diamond Light Source (Oxford, United
Kingdom). Data collection and reﬁnement statistics are summarized in Table S1.
Structure solution and reﬁnement. Diffraction data were processed and reduced using MOSFLM
(53) and Aimless (54) from the CCP4 suite (55) or autoPROC from Global Phasing Limited (56). The apo
form crystalized in the I4122 space group with one protomer per asymmetric unit. The ADP-G6P-OtsA
ternary complex crystallized in the P6222 space group, again with one protomer per asymmetric unit.
Initial phases were determined with Phaser (57) from the PHENIX software package (58) using the
structure of E. coli OtsA (PDB entry 1UQU) (32) as a search model. Model building was done with Coot
(59), and reﬁnement was performed in PHENIX (58). Structure validation was performed using Coot and
PHENIX tools (58, 59). All the ﬁgures were prepared with PyMOL (http://www.pymol.org).
Multiple sequence alignment. The multiple sequence alignment was performed with T-Coffee (60)
using the OtsA sequences of Mycobacterium thermoresistibile, Mycobacterium tuberculosis, Mycobacterium
leprae, Mycobacterium avium, Mycobacterium abscessus, Nocardia farcinica, Arthrobacter alpinus, Salmo-
nella enterica serovar Typhimurium, Escherichia coli, Candida albicans, Paraburkholderia xenovorans, and
Streptomyces venezuelae.
Prediction of mutations in ligand afﬁnity. To provide an insight on which residues to mutate, we
used mCSM-lig, a software program that predicts the effect of mutations in ligand afﬁnity (38) on the
X-ray crystal structure of OtsA with ADP-glucose (5JIO).
Enzymatic assays. Formation of T6P was assessed by a continuous colorimetric assay that followed
the release of NDP by measuring the oxidation of NADH at 340 nm, in the presence of pyruvate kinase
and lactate dehydrogenase. All reagents used were obtained from Sigma-Aldrich. The enzymatic
reactions (200-l reaction mixture) were performed at 37°C, and the reaction mixtures contained 50 mM
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Tris (pH 7.5), 200 mM NaCl, 10 mM MgCl2, 50 mM KCl, 0.3 mM NADH, 2.5 mM phosphoenolpyruvate (PEP),
10 units of pyruvate kinase-lactate dehydrogenase, 0.1 M enzyme, and various concentrations of G6P
and NDP-glucose to determine kinetic parameters.
To assess the speciﬁcity of OtsA for G6P, several compounds (F6P, mannose-6-phosphate,
glucosamine-6-phosphate, and G1P) were tested for their capacity to act as acceptor substrates, under
the conditions above, using ADP-glucose as the donor substrate. The effect of trehalose and T6P as
feedback inhibitors and of G1P, F6P, F16BP, CHES, 2PG, 3PG, cAMP, and 2OG as allosteric regulators was
tested under the conditions described above but with ﬁxed concentrations of G6P and ADP-glucose
(both 0.3 mM). The same conditions were used to test possible allosteric regulators for wild-type OtsA
and mutants Arg213Glu and Arg384Glu. All experiments were performed in triplicate in a PHERAstar
plate reader (BMG Labtech), and data were analyzed with Prism 5 (GraphPad Software).
To assess the inhibitory effect of ADP and the allosteric effect of phosphoenolpyruvate, an endpoint
assay was performed instead. Reaction mixtures (100 l) containing 50 mM Tris (pH 7.5), 200 mM NaCl,
10 mM MgCl2, 50 mM KCl, 4 M MtrOtsA, 0.3 mM ADP-glucose, 0.3 mM G6P, and various concentrations
of ADP and PEP were incubated at 37°C; the reactions were stopped at different time points with 10 l
of 1 M HCl; and the reaction mixtures were incubated for 1 min and neutralized with NaOH. The reaction
mixtures were diluted with 100 l acetonitrile, and the reactions were run at 25°C on a Waters I-class
ultrahigh-performance liquid chromatograph (UHPLC) with a photodiode array (PDA) detector (258 nm)
using an Acquity UHPLC ethylene-bridged hybrid (BEH) amide column (2.1 by 100 mm, 1.7 m). Gradient
elution (delivered at 0.13 ml/min) was employed using 80/20 acrylamide-water with 0.1% NH2OH (A) and
water with 0.1% NH2OH (B), which started at 90% A and decreased linearly to 55% A over 10 min.
Isothermal titration calorimetry. Binding interaction between OtsA and ligands was characterized
at 25°C, using a MicroCal ITC200 titration calorimeter (MicroCal). An OtsA concentration of 60 M was
used for all titrations. Ligands (1 mM) were injected in 2-l aliquots. Titration data were recorded in
20 mM Tris (pH 7.5)-500 mM NaCl. Data were analyzed by ﬁtting a simple single-site model using Origin
software (MicroCal).
Accession numbers. The coordinates and structure factors presented in this work have been
deposited in the Protein Data Bank under accession codes 5JIJ, 5K41, 5K42, 5JIO, 5L3K, 5K5C, and 5K44.
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